In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Start-Up Previews, January 2016

Executive Summary

In this month's issue of Start-Up, we profile Alcresta Pharmaceuticals, Gordian Surgical, International Biomedical Devices, NaviGate Cardiac Structures, ObsEva and SweetBio.

You may also be interested in...



Gordian Surgical Ltd.

To make laparoscopic procedures quicker, safer and less expensive, Israel-based Gordian Surgical Ltd. has developed a trocar with built-in closure capability. TroClose 1200 resembles a standard trocar, but is different in that it integrates two sutures and two biodegradable anchors that are positioned below the abdominal wall for the entire procedure.

International Biomedical Devices Inc.

An automated method to ensure a precise incision of the capsular bag for cataract surgery should soon be commercially available from International Biomedical Devices Inc. The Aperture Continuous Thermal Capsulotomy System (ApertureCTC) uses thermal energy delivered through a microincision to a 360-degree, small, steel ring placed on the anterior capsule to create a perfectly round and smooth incision in mere milliseconds.

NaviGate Cardiac Structures Inc.

For patients with severe or irreversible moderate mitral regurgitation, NaviGate Cardiac Structures Inc. is developing a catheter-guided compressible valved stent that fits within the diseased mitral valve in a beating heart.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV004464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel